Anclog Plus is a combination antiplatelet medication containing Clopidogrel and Aspirin, both of which work synergistically to inhibit platelet aggregation and reduce the risk of thrombotic cardiovascular events. Clopidogrel is a P2Y12 receptor antagonist, while Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), leading to decreased thromboxane A2 production. This dual action effectively prevents blood clot formation in patients at high risk of heart attacks, strokes, or other ischemic events.